Trinity Innovation Fund logo

Trinity Innovation Fund

Asia, Beijing, China, Beijing

Description

Trinity Innovation Fund is a fund management company that mainly focuses its investments on pharmaceutical innovation projects.

Investor Profile

Trinity Innovation Fund has made 4 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series C (25%)
  • Seed (25%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Neuroscience
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Trinity Innovation Fund frequently co-invest with?

A
North America, Massachusetts, United States, Waltham
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
LIGHTHOUSE
Asia, Beijing, China, Beijing
Co-Investments: 1
KTB Network
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Delta Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
CDIB Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by Trinity Innovation Fund?

Bivision

Shanghai, Shanghai, China

Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

BiopharmaBiotechnologyHealth Diagnostics
Series AJan 17, 2025
Amount Raised: $13,515,358
Rigerna

Fengtai, Beijing, China

Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues.

BiopharmaHealth CarePharmaceutical
SeedOct 21, 2024
Amount Raised: $14,046,917
Adcentrx Therapeutics

San Diego, California, United States

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

BiotechnologyPharmaceutical
Series AApr 24, 2023
Amount Raised: $51,000,000
XWPharma

Redwood City, California, United States

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.

BiopharmaBiotechnologyNeuroscience
Series CSep 17, 2020
Amount Raised: $40,000,000